Big biotech, Big pharma, Biotech, Partnering

IMS health and UCB form a pharma partnership

Posted on 23 October 2014

Tags: , , ,

IMS Health becomes pharma partner with UCB to help deliver greater business insights and improved operations, leveraging IMS Health’s Nexxus Commercial Application Suite and the IMS One intelligent cloud.

UCB will benefit from integrated information, streamlined operations and aligned decision making across critical commercial functions.

UCB teams in North America will now have access to the Nexxus Suite of interoperable Software-as-a-Service applications for marketing, sales planning, incentive compensation, performance management, mobile sales and master data management.

For further deal information visit Current Agreements (subscription required)

Related

Report: Top 50 Big Pharma Partnering and M&A Deal Trends

Report: Top 50 Big Biotech Partnering and M&A Deal Trends

Browse: Complete Current Partnering report catalog

View: Partnering Scorecard in CP Insight– view top life science partnering deals by value

View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making

View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply